Pulling the latest in this topic…
C-suite moves, stocks, investments, M&A
2730 briefings briefings in Business
A national security spacecraft maker goes Nasdaq-listed under QSPC, reshaping how defense hardware raises growth capital.
Their decades-old rivalry shifts from injections to pills, and Medicare timing turns the next launch race into a senior-access battle.
The side-effect profile of a new monthly GLP-1 rival lands near Novo Nordisk’s weekly target, sharpening the obesity race.
Fortune breaks down why Spotify’s internal talent marketplace, Echo, helped push internal hires above 40% in 2025.
A Maryland startup led by the former NASA chief is using a merger with a blank-cheque company to raise funding.
The €35 million penalty targets how Nintendo described Joy-Con drift on original Switch controllers and what regulators may do next.
The wiring upgrade for US data centres turns glassware into a strategic constraint, with jobs landing in North Carolina.
Steering Council orders new JIT development paused until a proper PEP is accepted, with removal after six months.
Two launches aimed at one practical bottleneck: how money moves smoothly between traders when outcomes settle.
A permanent injunction says stop. Meta says NSO kept running phishing and trick links anyway.
Record results for Lilly's next-generation weight loss drug intensify the race for GLP-1-like dominance and capital discipline.
A says autonomous offensive security is the antidote to frontier models exposing thousands of zero-days.
